Cargando…
IL-17–induced HIF1α drives resistance to anti–PD-L1 via fibroblast-mediated immune exclusion
Increasing evidence suggests that intratumoral inflammation has an outsized influence on antitumor immunity. Here, we report that IL-17, a proinflammatory cytokine widely associated with poor prognosis in solid tumors, drives the therapeutic failure of anti–PD-L1. By timing the deletion of IL-17 sig...
Autores principales: | Chen, Xing, Zhao, Junjie, Herjan, Tomasz, Hong, Lingzi, Liao, Yun, Liu, Caini, Vasu, Kommireddy, Wang, Han, Thompson, Austin, Fox, Paul L., Gastman, Brian R., Li, Xiao, Li, Xiaoxia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Rockefeller University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996325/ https://www.ncbi.nlm.nih.gov/pubmed/35389431 http://dx.doi.org/10.1084/jem.20210693 |
Ejemplares similares
-
IL-17 receptor-associated adaptor Act1 directly stabilizes mRNAs to
mediate IL-17 inflammatory signaling
por: Herjan, Tomasz, et al.
Publicado: (2018) -
The role of interleukin-17 in tumor development and progression
por: Zhao, Junjie, et al.
Publicado: (2019) -
TNF induces glycolytic shift in fibroblast like synoviocytes via GLUT1 and HIF1A
por: Koedderitzsch, Kathrin, et al.
Publicado: (2021) -
Screening of CRISPR-Cas9-generated point mutant mice using MiSeq and locked nucleic acid probe PCR
por: Vasu, Kommireddy, et al.
Publicado: (2021) -
TRAF Regulation of IL-17 Cytokine Signaling
por: Swaidani, Shadi, et al.
Publicado: (2019)